Mahalakshmi Laboratories Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 30.00 Cr
as on 06-07-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.71 Cr
as on 06-07-2024
- Satisfied Charges ₹ 17.08 Cr
as on 06-07-2024
- Revenue -49.31%
(FY 2023)
- Profit -57.84%
(FY 2023)
- Ebitda 5.63%
(FY 2023)
- Net Worth 0.53%
(FY 2023)
- Total Assets 5.82%
(FY 2023)
About Mahalakshmi Laboratories
The Corporate was formerly known as Ml Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 30.00 Cr.
The company currently has active open charges totaling ₹22.71 Cr. The company has closed loans amounting to ₹17.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
Padmaja Velecheti, Guntupalli Pratyusha, and Velecheti Sureshbabu serve as directors at the Company.
- CIN/LLPIN
U74999TG2006PTC051670
- Company No.
051670
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mahalakshmi Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Velecheti Sureshbabu  | Managing Director | 16-Nov-2006 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Padmaja Velecheti | Director | 31-Dec-2008 | Current |
| Guntupalli Pratyusha | Whole-Time Director | 06-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of Mahalakshmi Laboratories.
Mahalakshmi Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 49.31% decrease. The company also saw a substantial fall in profitability, with a 57.84% decrease in profit. The company's net worth moved up by a moderate rise of 0.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahalakshmi Laboratories?
In 2023, Mahalakshmi Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chemveda Life Sciences India Private LimitedActive 16 years 9 monthsGuntupalli Pratyusha is a mutual person
Sri Sujala Drugs & Intermediates Private LimitedActive 3 years 8 monthsPadmaja Velecheti and Velecheti Sureshbabu are mutual person
- Geoviq Lifesciences Private LimitedActive 5 years 6 months
Padmaja Velecheti and Velecheti Sureshbabu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 25 Nov 2021 | ₹5.49 Cr | Open |
State Bank Of India Creation Date: 09 Feb 2016 | ₹10.15 Cr | Open |
State Bank Of India Creation Date: 29 Dec 2014 | ₹7.07 Cr | Open |
How Many Employees Work at Mahalakshmi Laboratories?
Mahalakshmi Laboratories has a workforce of 56 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahalakshmi Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahalakshmi Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
